SAN vs. TEVA
SAN (Banco Santander, S.A.) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. SAN operates in Banks - Diversified (Financial Services), while TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, SAN returned 15.55%/yr vs -4.15%/yr for TEVA. At a 0.23 correlation, their price movements are largely independent.
Performance
SAN vs. TEVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SAN achieves a 4.95% return, which is significantly lower than TEVA's 6.57% return. Over the past 10 years, SAN has outperformed TEVA with an annualized return of 15.55%, while TEVA has yielded a comparatively lower -4.15% annualized return.
SAN
- 1D
- 0.08%
- 1M
- -0.98%
- YTD
- 4.95%
- 6M
- 11.81%
- 1Y
- 55.12%
- 3Y*
- 58.01%
- 5Y*
- 28.22%
- 10Y*
- 15.55%
TEVA
- 1D
- -2.72%
- 1M
- -6.91%
- YTD
- 6.57%
- 6M
- 17.40%
- 1Y
- 87.17%
- 3Y*
- 65.55%
- 5Y*
- 25.39%
- 10Y*
- -4.15%
SAN vs. TEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SAN Banco Santander, S.A. | 4.95% | 164.72% | 14.96% | 46.20% | -6.62% | 10.41% | -21.99% | -2.32% | -28.49% | 32.28% |
TEVA Teva Pharmaceutical Industries Limited | 6.57% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
Correlation
The correlation between SAN and TEVA is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 1990 | 0.23 |
The correlation between SAN and TEVA shifts across timeframes, from 0.23 (all time) to 0.40 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
SAN:
$178.48B
TEVA:
$39.21B
SAN:
$1.06
TEVA:
$1.34
SAN:
11.45
TEVA:
24.87
SAN:
0.60
TEVA:
0.19
SAN:
2.48
TEVA:
2.24
SAN:
1.68
TEVA:
4.76
SAN:
$74.92B
TEVA:
$17.35B
SAN:
$46.97B
TEVA:
$9.03B
SAN:
$21.14B
TEVA:
$3.05B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SAN vs. TEVA — Risk / Return Rank
SAN
TEVA
SAN vs. TEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Banco Santander, S.A. (SAN) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SAN | TEVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.58 | ||
| Sortino ratioReturn per unit of downside risk | -1.11 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.43 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.73 | 4.02 | -1.29 |
| Martin ratioReturn relative to average drawdown | 8.45 | 10.94 | -2.49 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SAN | TEVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.68 | 2.25 | -0.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.84 | 0.59 | +0.25 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | -0.09 | +0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.31 | -0.09 |
Drawdowns
SAN vs. TEVA - Drawdown Comparison
The maximum SAN drawdown since its inception was -82.94%, smaller than the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for SAN and TEVA.
Loading charts...
Drawdown Indicators
| SAN | TEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.94% | -90.89% | +7.95% |
Max Drawdown (1Y)Largest decline over 1 year | -20.29% | -21.79% | +1.50% |
Max Drawdown (3Y)Largest decline over 3 years | -20.29% | -43.70% | +23.41% |
Max Drawdown (5Y)Largest decline over 5 years | -43.63% | -43.70% | +0.07% |
Max Drawdown (10Y)Largest decline over 10 years | -73.84% | -88.41% | +14.57% |
Current DrawdownCurrent decline from peak | -6.81% | -50.84% | +44.03% |
Average DrawdownAverage peak-to-trough decline | -30.67% | -32.00% | +1.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.55% | 8.00% | -1.45% |
Volatility
SAN vs. TEVA - Volatility Comparison
The current volatility for Banco Santander, S.A. (SAN) is 8.71%, while Teva Pharmaceutical Industries Limited (TEVA) has a volatility of 9.18%. This indicates that SAN experiences smaller price fluctuations and is considered to be less risky than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SAN | TEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.71% | 9.18% | -0.47% |
Volatility (6M)Calculated over the trailing 6-month period | 26.85% | 23.54% | +3.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.12% | 38.97% | -5.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.78% | 42.94% | -9.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.87% | 47.34% | -11.47% |
Dividends
SAN vs. TEVA - Dividend Comparison
SAN's dividend yield for the trailing twelve months is around 2.30%, while TEVA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAN Banco Santander, S.A. | 2.30% | 2.11% | 4.63% | 3.58% | 3.83% | 2.71% | 0.00% | 6.20% | 5.83% | 4.60% | 3.29% | 7.06% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
SAN vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between Banco Santander, S.A. and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SAN vs. TEVA - Profitability Comparison
SAN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported a gross profit of 12.95B and revenue of 31.44B. Therefore, the gross margin over that period was 41.2%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
SAN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported an operating income of 5.11B and revenue of 31.44B, resulting in an operating margin of 16.3%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
SAN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported a net income of 5.54B and revenue of 31.44B, resulting in a net margin of 17.6%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
Frequently Asked Questions
SAN and TEVA have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TEVA has higher volatility (9.18%) compared to SAN (8.71%). In terms of maximum drawdown, SAN dropped -82.94% vs TEVA's -90.89%.
TEVA currently has the higher Sharpe Ratio (2.25 vs 1.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SAN and TEVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer